Bioengineering
Acceleron Pharma to Present ACE-011 Bone Growth Data at the ASBMR 29th Annual Meeting
Published in Drug Week, August 24th, 2007
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, today announced it will present the final results for the phase 1 clinical trial of ACE-011, its novel anabolic therapy for the treatment of bone loss at The American Society for Bone and Mineral Research (ASBMR) 29th Annual Meeting to be held in Honolulu, Hawaii, USA, September 16 - 19, 2007. The oral presentation is titled, "A Single Dose of ACE-011 Is Associated with Increases in Bone Formation and Decreases in Bone Resorption Markers in Healthy, Postmenopausal Women", and will be presented on Tuesday September 18, 2007 at 11:15-11:30 a.m. in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2007-08-24)
More Articles from Drug Week
- Adverse Drug Reactions
Gastroenterologist-directed sedation safe and effective for endoscopic procedures - Alzheimer Disease
Researchers link metal ions to neurodegenerative disease - Asthma
ESRF lightsource helps tailoring new treatments against asthma - Attention Deficit Hyperactivity Disorder
ADHD Appears to Be Associated With Depressed Dopamine Activity in the Brain - Attention Deficit Hyperactivity Disorder
Gene Variant Is Associated With Brain Anatomy, Clinical Course of ADHD - Battery Technology
Miniature Implanted Devices Could Treat Epilepsy, Glaucoma - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
